Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-001855
Filing Date
2023-02-02
Accepted
2023-02-02 20:08:57
Documents
1
Period of Report
2023-01-20

Document Format Files

Seq Description Document Type Size
1 form4-02032023_010247.html 4  
1 form4-02032023_010247.xml 4 4268
  Complete submission text file 0001415889-23-001855.txt   5857
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341
Business Address
Lim Bryant David (Reporting) CIK: 0001752888 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 23583274